Skip to main content
. 2023 May 31;16(5):1176–1184. doi: 10.14202/vetworld.2023.1176-1184

Table-4.

Factorial two-way ANOVA test results on lymphocyte cell counts with control and treatment groups.

Treatment Lymphocyte Cell Count Conclusion

Day 1 Day 2 Day 4 Day 6
Sofra-tulle control (K+) 38.00h,i ± 1.00 35.33g,h,i ± 0.58 33.00c,d,e,f,g ± 1.00 30.67b,c,d,e,f ± 0.58 p = 0.00 (there is a significant difference)
NaCl control (K−) 38.33i ± 1.53 36.00g,h,i ± 1.00 33.67e,f,g,h ± 1.53 31.67b,c,d,e,f,g ± 0.58
Red-laser therapy (P1) 33.33d,e,f,g ± 0.58 30.00b,c,d,e,f ± 0.00 28.67a,b,c ± 0.58 24.67a ± 0.58
Blue-laser therapy (P2) 34.00f,g,h,i ± 2.65 32.00b,c,d,e,f,g ± 1.00 29.33b,c,d,e ± 1.15 28.00a,b ± 1.00
Ozone therapy (P3) 35.33g,h,i ± 2.52 33.67e,f,g,h ± 1.53 31.67b,c,d,e,f,g ± 0.58 29.67b,c,d,e,f ± 0.58
Red-laser therapy+ozone (P4) 33.33d,e,f,g ± 2.08 32.00b,c,d,e,f,g ± 2.00 29.33b,c,d,e ± 0.58 28.33a,b ± 0.58
Blue-laser therapy+ozone (P5) 33.00c,d,e,f,g ± 3.00 32.00b,c,d,e,f,g ± 3.00 29.00a,b,c,d ± 1.00 28.33a,b ± 1.53

ANOVA=Analysis of variance, Significant differences are denoted by different letters within the same column (p < 0.05)